COMMUNIQUÉS West-GlobeNewswire

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
02/12/2025
- FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent prostate cancer - JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ [...]
Reema Health Tackles Medicaid Challenges with $19M Series B from LRVHealth and Optum Ventures
02/12/2025
Engagement Model Blending Humans and Technology Drives 3X ROI to Medicaid MCOs MINNEAPOLIS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Reema Health , the human powered and tech-enabled solution that engages hard-to-reach members [...]
Aeroflow Health Celebrates Giving Tuesday Through Donations to Western North Carolina Organizations
02/12/2025
Aeroflow donates several thousand dollars across seven local organizations based in its home state ASHEVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering healthcare company that leverages [...]
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
02/12/2025
– Dr. Tagliaferri is a proven executive recognized for advancing innovative therapies across immunology, oncology and other serious diseases – SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. ( [...]
BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
02/12/2025
MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BetaGlue ® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing an innovative radiotherapy solution for the targeted [...]
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
02/12/2025
The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients with aging-related frailty with inflammaging and also to treat patients [...]
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
02/12/2025
Global assignment of this unique name enhances international clarity, strengthens regulatory positioning, and supports olastrocel’s advancement across large unmet-need global markets PHOENIX, Dec. 02, 2025 (GLOBE [...]
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
02/12/2025
SARASOTA, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO” or the “Company”) (NASDAQ: IVF), a healthcare company focused on the fertility market, today announced that it has entered into a securities [...]
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
02/12/2025
TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Precision Neuroscience Recognized for Innovation and Responsible Technology with Two Industry Awards
02/12/2025
NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision™) a leader in brain–computer interface (BCI) technology, has been named to Inc. Magazine’s 2025 Best in Business list in the Best [...]
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
02/12/2025
The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the biopharmaceutical value chain Clients to benefit from accelerated timelines, as well as reduced [...]
Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
02/12/2025
Berlin, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tacalyx, a privately held biotech company focused on developing novel TACA (Tumour Associated Carbohydrate Antigens) cancer therapies, announces the appointment of Jean [...]
The Ensign Group Grows Operations in Colorado
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Increases Operations in Arizona
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
The Ensign Group Adds Real Estate and Operations in Kansas
02/12/2025
SAN JUAN CAPISTRANO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Alberta Cancer Foundation launches 'The Time Store' campaign to bring more moments to Albertans facing cancer
02/12/2025
Province-wide campaign asks Albertans to give more meaningful moments for people like patient Colin Dalziel EDMONTON, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) -- This Giving Tuesday and throughout the holiday season, [...]
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise
02/12/2025
Expert retina and uveitis specialists will help support the growth and innovation of ANI’s ophthalmology and retina franchise for a meaningful impact on patients PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- ANI [...]
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
02/12/2025
BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it [...]
Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook
02/12/2025
VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) is pleased to provide a corporate update following its recently released Q3 financial results and [...]

Pages